The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas
Clinical trial NCT02701257 · TERMINATED
Trial details
- NCT number
- NCT02701257
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.